This characteristic was in line with the Guidelines on Prostate Cancer of European Association of Urology using f/t PSA and PSAD to evaluate whether a prostate biopsy should be performed in the ‘grayzone’, PSA 4–10 ng/mL. This evidence concerns the gene KLK3 and prostate cancer.